Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2020, Health of the Nations: Perspectives for a New India
THE INDUSTRIAL EVOLUTION OF HEALTHCARE It is a transformative fact today that most countries and their citizens draw on essential medicines and vaccines designed and manufactured and then traded across hundreds and often, thousands of miles. Health technologies include both mature and innovative products, in some cases, entirely disrupting patient experiences, the medical profession, and the organization of industries. Several sub-sectors such as medicines, vaccines, diagnostic kits, medical devices, and surgical instruments are produced and governed within and across national boundaries. These technologies may be regulated for a range of health and safety reasons, and often through industrial policies. New economics for health focused on technological change and the evolutionary aspects of industrial organization in the health industry may therefore look different from health economics as we know it today.
Bioscience Journal, 2018
2019
Healthcare has experienced a deep transformation characterized by significant growth in expenditures during the twentieth century. Today, it represents one of the fastest growing sectors of the economy. While estimates of health expenditures came out to about 1% of a country’s total GDP in 1900, OECD statistics put that proportion at 4–6% in 1970 (5.2% in France; 5.7% in Germany; 4.4% in Japan; 4% in the UK; and 6.2% in the US) and on a steady increase through the present day. In 2015, health expenditures accounted for 11% of the GDP in France, 11.1% in Germany, 11.2% in Japan, 9.8% in the UK, and 16.9% in the US. Moreover, this phenomenon is not limited to developed countries. Emerging countries follow the same trend, too, with health expenditures that went from 4% to 6% of GDP in China and 4% to 5% in India between 1995 and 2014, for example. Throughout the world, endless growth of health expenditures has led to financial concerns for governments of all kinds. Scholars have also e...
Health economics, as an interdisciplinary science, has experienced exceptionally bold evolution through the past eight decades. Generations of committed scholars have built up huge body of knowledge and developed a set of methodological tools to assist health-care authorities with resource allocation process. Following its conception at the US National Bureau of Economic Research and Ivy League US Universities, this science has spread across the Globe. It has adapted to a myriad of local conditions and needs of the national health systems with diverse historical legacies, medical services provision , and financing patterns. Challenge of financial sustainability facing modern day health systems remains primarily attributable to population aging, prosperity diseases, large scale migrations, rapid urbanization, and technological innovation in medicine. Despite promising developments in developing countries with emerging BRICS markets on the lead, rising out-of-pocket health spending continues to threaten affordability of medical care. Universal health coverage extension will likely remain serious challenge even for some of the most advanced OECD nations. These complex circumstances create strong drivers for inevitable further development of health economics. We believe that this interdisciplinary health science shall leave long-lasting blue print to be visible for decades to come.
The Quarterly Review of Economics and Finance, 2004
Complementary Medicine Research, 2018
2009
The medical technology sector is characterised by a pronounced innovative strength, high knowledge intensity and social relevance due to its contributions to the health care of the population. In Germany, the situation of this future-oriented sector can be characterised as good overall: The scientific-technical basis of medical technology research and development (R&D) is internationally outstanding in many areas. As an industry, German medical technology manufacturers are very well positioned and occupy a leading place on the world market alongside the USA and Japan. Despite this favourable starting position, the industry faces a number of challenges resulting from intensifying international competition, the internationalisation of production and distribution structures and the changing conditions in the health care sector. Subject and objective of the study The promotion of medical technology and the creation of the most favourable framework conditions possible also pose considera...
Masonpedia | ResearchGate, 2024
Başlığı ve tamamlayıcısı alt başlığı okuduktan sonra eminim ki kafalarda sayısız sorular dolaşacak. Amaç da bu zaten; olanı kabullenmekten ziyade değişimi anlayarak yorumlamak, becerebildiğimiz ölçüde elbette... Bunu bir ölçüde kolaylaştırmak için okur adına soruları da yazımın içine ekledim. Sıradan bir okuma yerine sohbet havası katması da cabası. Umarım hoşunuza gider, sadece satırları değil satır aralarını okumaktan da keyif alırsınız. Çalışmanın akıcılığını sağlamak için araya serpiştirilen sorular da bir anlamda bunu hedefliyor. Makale okumak keyiflidir ama sohbet daha keyiflidir, üstelik daha akılda kalıcıdır.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Labour/Le Travail, 1997
Revista Brasileira de Educação Médica, 2024
Lectio Socialis, 2024
Renaissance and Reformation 45, no. 1, 2022
HEROM Volume 8, 2019
Journal of African Foreign Affairs (JoAFA), 2019
The Journal of Thoracic and Cardiovascular Surgery, 2020
Journal of Microbiological Methods, 1999
International journal of biological macromolecules, 2015
IEEE Microwave and Guided Wave Letters, 1992
Process Biochemistry, 2011
Journal of Cognitive Neuroscience, 2010
Advances in Higher Education and Professional Development, 2019
Journal of Tropical Pediatrics, 2009
British Journal of Music Therapy, 2001